Research Highlights
New HIV Vaccine Design Shows Promise in Creating Protective Antibodies
Sep 3, 2024 Features
Researchers at the University of Amsterdam, in collaboration with the Batista Lab at the Ragon Institute, have developed a potential new approach for an HIV vaccine. The study, published in Science Immunology, focuses on creating a vaccine component that can stimulate the immune system to produce powerful antibodies against HIV. Titled “Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 […]
Alex Shalek Appointed Director of IMES at MIT
Jul 30, 2024 Features
We are thrilled to announce that Ragon faculty member Alex Shalek, PhD, has been appointed as the new Director of the Institute for Medical Engineering and Science (IMES) at MIT, effective August 1, 2024. Shalek joined the Ragon Institute a decade ago, playing a pivotal role in advancing our mission. His innovative work spans genomics, […]
Evavold Presents at RCCHU Seminar
Jul 16, 2024 Features
On July 9, Ragon faculty member and Early Independence Fellow Charles Evavold, PhD, participated in a special seminar as part of the Science Seminar Series @RCCHU titled “Synthetic Biology Strategies for Human Health: From Yeasts to Immune Cells.” Hosted by the Real Colegio Complutense at Harvard (RCCHU) and Harvard Medical School, this seminar explored innovative […]
New target in sight for HIV vaccine development
May 30, 2024 Features
Batista Lab postdoctoral fellow Rashmi Ray, PhD, was the first author of the paper published in Nature. Decades into the HIV epidemic, there is as yet no effective vaccine to prevent new cases. In a recent Nature Immunology article (Ray et al.), the Batista lab of the Ragon Institute has preclinically validated a new HIV […]
Related Labs
Allen Lab
Principal Investigator
Todd Allen, PhD
- T Cell Immunotherapy
- HIV Evolution and Transmission
Balazs Lab
Principal Investigator
Alejandro B. Balazs, PhD
- Engineering Immunity Against Infectious Disease
Barczak Lab
Principal Investigator
Amy Barczak, MD
- Host-pathogen interactions in mycobacterial infection
Batista Lab
Principal Investigator
Facundo Batista, PhD
- B cells
- Antibodies
- Preclinical vaccinology
Bryson Lab
Principal Investigator
Bryan Bryson, PhD
- Immune control of mycobacteria
Dekosky Lab
Principal Investigator
Brandon J. DeKosky, PhD
- Efficient Engineering and Discovery of Adaptive Immune Receptors
Evavold Lab
Principal Investigator
Charles Evavold, PhD
- Synthetic immunity and cell death regulation
Gaiha Lab
Principal Investigator
Gaurav D. Gaiha, MD, DPhil
- T cells
- Vaccines
- Immune Control
Garcia-Beltran Lab
Principal Investigator
Wilfredo Garcia-Beltran, MD, PhD
- NK cell biology
- Immune/cellular therapy
Ghebremichael Lab
Principal Investigator
Musie Ghebremichael, PhD
- Application and development of statistical methods
Juelg Lab
Principal Investigator
Boris D. Juelg, MD, PhD
- Natural infections informing immunotherapies
Kwon Lab
Principal Investigator
Douglas S. Kwon, MD, PhD
- Mucosal Immunology
- Microbiome
- HIV
- Clinical Research
- Emerging Infectious Diseases
Lichterfeld Lab
Principal Investigator
Mathias D. Lichterfeld, MD, PhD
- Clinical Trials
- Single Cell assays
- HIV Cure
Lingwood Lab
Principal Investigator
Daniel Lingwood, PhD
- Programing vaccine antibody responses
Liu Lab
Principal Investigator
Sophia Liu, PhD
- Building tools to characterize spatial and temporal immune cell interactions
Pillai Lab
Principal Investigator
Shiv Pillai, MD, PhD
- B-cell biology and T-B collaboration
Ringel Lab
Principal Investigator
Alison Ringel, PhD
- Molecular adaptations in immune cells enabling function under stress
Schmidt Lab
Principal Investigator
Aaron Schmidt, PhD
- Protein Engineering
- Therapeutic Development
- Viral Evolution
Shalek Lab
Principal Investigator
Alex K. Shalek, PhD
- Single-Cell Genomics
- Systems Immunology
Walker Lab
Principal Investigator
Bruce D. Walker, MD
- HIV
- Virus-specific T cells
- Elite controllers
Wong Lab
Principal Investigator
Harikesh Wong, PhD
- Intercellular Communication
- Tissue Microenvironment
- Quantitative & Systems Immunology
Support Our Vital Research
As a non-profit institution, the Ragon relies on the generosity of our benefactors to advance our world-changing research. Whether giving to labs at the Ragon, outreach programs in the Boston area, or research programs in South Africa, one of the greatest catalysts in going from novel ideas to treatments and cures is flexible philanthropic support from donors — and your gift could make all the difference.
Program for Immunophysiology and Disease
Revealing mechanisms of immune control and disease pathogenesis to prepare for and protect against future global health threats.
Program for Patient Focused Immunology
Bringing observations from the bedside to the bench and back, worldwide.